NUTRIFLEX OMEGA SPECIALIZED Emulsion for infusion South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

nutriflex omega specialized emulsion for infusion

b. braun integrated pharmaceutical plant - emulsion for infusion - not indicated - each 1000,0 ml contains glucose monohydrate equivalent to glucose 144,0 g and sodium dihydrogen phosphate dihydrate 2,496 g and zinc acetate dihydrate 7,024 mg and medium-chain triglycerides 20,0 g and soybean oil 16,0 g and omega-3 fatty acids 4,0 g and isoleucine 3,284 g and leucine 4,384 g and lysine hydrochloride equivalent to lysine 3,186 g and methionine 2,736 g and phenylalanine 4,916 g and threonine 2,540 g tryptophan 0,800 g and valine 3,604 g and arginine 3,780 g and histidine hydrochloride monohydrate equivalent to histidine 1,753 g and alanine 6,792 g and aspartic acid 2,100 g and glutamic acid 4,908 g and glycine 2,312 g and proline 4,760 g and serine 4,200 g and sodium hydroxide 1,171 g and sodium chloride 0,378 g and sodium acetate trihydrate 0,250 g and potassium acetate 3,689 g and magnesium acetate tetrahydrate 0,910 g and calcium chloride dihydrate 0,623 g and sodium 53,6 mmol and potassium 37,6 mmol and magnesium 4,2 mmol and calcium 4,2 mmol and zinc 0,03 mmol and chloride 48,0 mmol and acetate 48,0 mmol and phosphate 16,0 mmol

NUTRIFLEX OMEGA PLUS Emulsion for infusion South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

nutriflex omega plus emulsion for infusion

b. braun integrated pharmaceutical plant - emulsion for infusion - not indicated - each 1000,0 ml contains glucose monohydrate equivalent to glucose 120,0 g and sodium dihydrogen phosphate dihydrate 1,872 g and zinc acetate dihydrate 5,264 mg and medium-chain triglycerides 20,0 g and soybean oil 16,0 g and omega-3 fatty acids 4,0 g and isoleucine 2,256 g and leucine 3,008 g and lysine hydrochloride equivalent to lysine 2,184 g and methionine 1,880 g and phenylalanine 3,368 g and threonine 1,744 g and tryptophan 0,544 g and valine 2,496 g and arginine 2,592 g and histidine hydrochloride monohydrate equivalent to histidine and 1,202 g alanine and 4,656 g aspartic acid and 1,440 g glutamic acid and 3,368 g and glycine 1,584 g and proline 3,264 g serine and 2,880 g sodium hydroxide and 0,781 g sodium chloride and 0,402 g sodium acetate trihydrate and 0,222 g potassium acetate and 2,747 g magnesium acetate tetrahydrate 0,686 g and calcium chloride dihydrate and 0,470 g sodium and 40,0 mmol and potassium 28,0 mmol and magnesium 3,2 mmol and calcium 3,2 mmol and zinc 0,024 mmol and chloride 36,0 mmol and acetate 36,0 mmol and phosphate 12,0 mmol

GNC TriFlex Joint Support Australia - English - Department of Health (Therapeutic Goods Administration)

gnc triflex joint support

jade international auz pty ltd - bovine sodium chondroitin sulfate, quantity: 400 mg; dimethyl sulfone, quantity: 300 mg; sodium hyaluronate, quantity: 1.67 mg; glucosamine hydrochloride, quantity: 500 mg (equivalent: glucosamine, qty 415.53 mg) - tablet, film coated - excipient ingredients: silicon dioxide; povidone; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; hypromellose; macrogol 8000; titanium dioxide; carnauba wax - decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/supports healthy joint cartilage growth/development/production ; helps maintain/support joint cartilage health ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling ; maintain/support joint mobility/flexibility ; decrease/reduce/relieve mild joint stiffness

TERUFLEX BLOOD BAG SYSTEM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) (anticoagulant citrate phosphate dextrose ad United States - English - NLM (National Library of Medicine)

teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) (anticoagulant citrate phosphate dextrose ad

terumo corporation - anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), adenine (unii: jac85a2161) (adenine - unii:jac85a2161) - anhydrous citric acid 2.99 g in 1000 ml - for the collection of 250 ml of whole blood revised 2015-12 n-bb-a 3 full prescribing information * sections or subsections omitted from the full prescribing information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17]. 1.   indications and usage 1.1.   read these instructions carefully before use. 1.2.   rx only. 1.3.   intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4.   for the collection of 250 ml ±10% whole blood:     1.4.1.    from elderly, pediatric, or smaller autologous donors who may not tolerate larger blood collections.     1.4.2.    for blood collections as directed by a patient's physician. 1.5.   note : production of platelets and plasma is not intended with this product.

TERUFLEX BLOOD BAG SYSTEM WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RE United States - English - NLM (National Library of Medicine)

teruflex blood bag system with diversion blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) re

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - 1.1. read these instructions carefully before use. 1.2. rx only. 1.3. intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4. for the collection of 450 ml ±10% or 500 ml ±10% whole blood. 1.5. integral diversion blood sampling arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the whole blood unit. 1.6. for further processing, use standard component processing techniques. this device is for use by trained individuals. intended use the donorcare® needle guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor. single use only. preparation 1. move the donorcare on the tubing ensuring that it slides easily and the arrow is pointing toward the needle hub. 2. ensure that the three lock points on the donorcare are locked closed. whole blood collection 3. perform the phlebotomy as per your institution's standard operating procedures

TERUFLEX BLOOD BAG SYSTEM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) (anticoagulant citrate phosphate dextrose ad United States - English - NLM (National Library of Medicine)

teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) (anticoagulant citrate phosphate dextrose ad

terumo corporation - anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), adenine (unii: jac85a2161) (adenine - unii:jac85a2161) - anhydrous citric acid 2.99 g in 1000 ml - full prescribing information *sections or subsections omitted from the full prescribing information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17]. 1.    indications and usage 1.1.   read these instructions carefully before use. 1.2.   rx only. 1.3.   intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4.   for the collection of 450 ml ±10% or 500 ml ±10% whole blood. 1.5.   integral blood sampling arm for obtaining donor samples for laboratory testing after collection of the whole blood unit. 1.6.   for further processing, use standard component processing techniques. donorcare® needle guard this device is for use by trained individuals. intended use the donorcare® needle guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor. single use only. preparation 1. move the donorcare on the tubing ensuring that it slides ea

TERUFLEX BLOOD BAG SYSTEM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) (anticoagulant citrate phosphate dextrose ad United States - English - NLM (National Library of Medicine)

teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) (anticoagulant citrate phosphate dextrose ad

terumo corporation - anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), adenine (unii: jac85a2161) (adenine - unii:jac85a2161) - revised 2011-11 n-bb-ca-a 5 bb89x505+5 full prescribing information *sections or subsections omitted from the full prescribing information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17]. 1.   indications and usage 1.1.   read these instructions carefully before use. 1.2.   rx only 1.3.   intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4.   for the collection of 450 ml +/- 10% whole blood. 1.5.   for further processing, use standard component processing techniques.

KELATO NUTRIFLEX POWDER FOR HORSES Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kelato nutriflex powder for horses

kelato animal health a div of evolution animal health pl - refer to label - oral powder, pre-mix - refer to label misc active 0.0 undefined - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - improve joint function

MOTRIFLEX LIQUID GELS naproxen sodium 220 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

motriflex liquid gels naproxen sodium 220 mg capsule blister pack

johnson & johnson pacific pty ltd - naproxen sodium, quantity: 220 mg - capsule, soft - excipient ingredients: povidone; lactic acid; gelatin; patent blue v; lecithin; isopropyl alcohol; macrogol 600; glycerol; purified water; partially dehydrated liquid sorbitol; medium chain triglycerides; propylene glycol - provides temporary relief of pain and/or inflammation associated with muscular aches and pains, sprains and strains, backache, osteoarthritis, rheumatic pain, arthritis, headache, period pain, dental pain and cold & flu. reduces fever.